AcademyHealth Research Meeting Barbara Greenberg, Ph.D. Office of Science and Data Policy Research ASPE, HHS June 8, 2004.

Slides:

Advertisements

Similar presentations

FDA QS reg/CLIA Comparison: Overview

Advertisements

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDAs website for reference purposes only. It.

Why documentation is relevant in implementing the NMP Dr Ross Maxwell Member, National Medicines Policy Committee Session 5: The Relevance of National.

Thailand National Focal Point for IFCS Chemical Safety Section Food and Drug Administration Ministry of Public Health July 2003.

11 Opportunities to Improve Care for Persons with Disabilities: The Community Living Initiative IMPLEMENTING NATIONAL HEALTH REFORM IN A DIFFICULT ECONOMIC.

COUNTRY HEALTH PROFILE MYANMAR. NATIONAL HEALTH SYSTEM National Health Committee (NHC), the highest level policymaking body National Health Policy in.

Introduction to Regulation

Environmental and Structural Factors Influencing the Politics of Pharmaceuticals in How Public Opinion, New Leadership, the SOTU and Governance.

Health IT Standards Committee Federal Health IT Strategic Plan December 10, 2014 Seth Pazinski Director, Office of Planning, Evaluation, and.

July 3, 2015 New HIE Capabilities Enable Breakthroughs In Connected And Coordinated Care Delivery. January 8, 2015 Charissa Fotinos.

Consumer Work Group Presentation Federal Health IT Strategic Plan January 9, 2015 Gretchen Wyatt Office of Planning, Evaluation, and Analysis.

A Perspective on Canadian Initiatives in Health Care Quality HL7 Clinical Quality Work Group June 26,

J. Nadine Gracia, MD, MSCE Deputy Assistant Secretary for Minority Health (Acting) Office of Minority Health U.S. Department of Health and Human Services.

Federal Aviation Administration CLEEN (Continuous Lower Energy, Emissions and Noise) Program Technologies Development AIAA Aerospace Sciences Meeting Jim.

1 CPIOUpdate.PPACMeeting PTODraft Performance Improvement Strategy Chief Performance Improvement Officer June 2009.

COMPARATIVE EFFECTIVENESS RESEARCH Public Policy Interest and Issues Jeanne Lambrew, PhD Associate Professor LBJ School of Public Affairs National Health.

Food and Agriculture Sector Coordinating Councils John L. Williams, DVM U.S. Department of Agriculture AFDO Annual Conference Kansas City, MO June 7, 2005.

Improving the competitiveness of the pharmaceutical industry Dominique Limet Senior Vice-President and Area Director Southern and Eastern Europe.

The U. S. National Strategy for Global Supply Chain Security Neema Khatri Office of International Affairs U.S. Department of Homeland Security.

1 Workforce Development: The Role of a Board of Health National Association of Local Boards of Health, 10th Annual Conference July 11, 2002 J. Fred Agel,

City Council October 21, 2013 Strategic Planning Retreat Next Steps.

1 JUSTICE LAW AND ORDER SECTOR SWAP DEVELOPMENT & IMPLEMENTATION PROCESS.

THE NATIONAL INFLUENZA VACCINE SUMMIT: UPDATE Raymond A. Strikas, M.D. Immunization Services Division National Immunization Program Coordinating Center.

Public Health Data Standards Consortium 2004 – 2005 Directions

ARRA and HHS Data Policy Initiatives Academy Health NAHDO All Payer All Claims Data Bases James Scanlon, HHS Deputy Assistant Secretary/ASPE.

Overview June,  Sub-recipients grant applications will go to ADAMHS/ADAS Boards only.  ADAMHS/ADAS Boards will be expected to identify a primary.

Starting the Planning Process & Assessing Needs HSC 489.

Federal Interagency Forum on Child and Family Statistics Martha Moorehouse Director, Children and Youth Policy Office of the Assistant Secretary for Planning.

United States Department of Health & Human Services Office of the Assistant Secretary for Preparedness and Response Cheryl Levine, Ph.D. At-Risk IndividualsTeam.

Developing National Health Information Infrastructure (NHII) in the U.S. William A. Yasnoff, MD, PhD, FACMI Senior Advisor National Health Information.

WEDI ICD-10 Update National Committee on Vital and Health Statistics Subcommittee on Standards June 10, 2014 Jim Daley, Chairman, WEDI Director, IT Risk.

The United States Health Information Technology Strategy Lammot du Pont Office of the National Coordinator for HIT Funding Health IT, Government Perspectives.

BASELINE SURVEYS AND MONITORING OF PHARMACEUTICAL SITUATION IN COUNTRIES. Joseph Serutoke NPO/EDM WHO Uganda November 2002.

Integrating Administrative Records into the Federal Statistical System 2.0 Shelly Wilkie Martinez Statistical and Science Policy U. S. Office of Management.

July June 2014 Presented by Leah Howard & Ryan White Upper Dublin School District Educational Technology Plan.

J. James Rohack, MD, FACC President, AMA Director, Scott & White Center for Healthcare Policy Professor of Medicine and Humanities, TAMHSC Information.

Developing Proposals for a System of Indicators on the Nation’s Environment (the SINE) H. Theodore Heintz, Jr. Indicator Coordinator White House Council.

Local Sustainability, Local Government and the State Drivers Participation Partnerships.

Shaping a Health Statistics Vision for the 21 st Century 2002 NCHS Data Users Conference 16 July 2002 Daniel J. Friedman, PhD Massachusetts Department.

Governance e-Transformation Launch of Moldova-India Dialogue & Collaboration Chisinau January 21, Governance e-Transformation Launch of Moldova-India Dialogue.

The Integrated National Biodefense Portfolio Initiative “One-Portfolio” Chemical Biological Defense Acquisition Initiatives Forum (CBDAIF) May 6, 2009.

Research Agenda of the Office of the Assistant Secretary for Planning and Evaluation (OASPE) Annual Research Meeting of AcademyHealth San Diego, California.

Neville Cooney ABS November 2005 WA Justice Research Conference ABS Initiatives in Crime and Justice - from NIDP to RADLs.

Stratis Health Prevention Project June 30, Stratis Health Stratis Health is a non-profit organization that leads collaboration and innovation.

Agency for Healthcare Research and Quality Advancing Excellence in Health Care The “Centers for Education & Research on Therapeutics” (CERTs)

The Science of Public Reporting September 10, 2012 AHRQ 2012 Annual Conference Lunch & Learn Session Celeste Torio, PhD, MPH Staff Service Fellow AHRQ.

Outcome On completion of this unit the student should be able to describe and evaluate programs implemented by international and Australian government.

FDA Standards Development and Implementation Randy Levin, M.D. Director, Office of Information Management Center for Drug Evaluation and Research Food.

Research in the Office of Vaccines Research and Review: Vision and Overview Jesse Goodman, M.D., M.P.H. Director, Center for Biologics Evaluation and Research.

1Office of the Federal Coordinator for Meteorology OFCM OFCM Special Session: Uncertainty in Atmospheric Transport and Diffusion (ATD) Models Setting the.

Electronic Clinical Quality Measures – Session #1 ONC Resource Center.

Systems, Data and HIPAA from a Medicaid Perspective Rick Friedman, Director Division of State Systems Center for Medicare and Medicaid US Dept Health &

Barnstable County Regional Substance Abuse Council Updated October 2015 Barnstable County Department of Human Services |

Improving the Population’s Health Through Standards National Center for Health Statistics 2002 Data Users Conference July 16, 2002 Data Policy and Standards.

BP10 Public Health Emergency Preparedness Grant Update Health & Medical Subpanel Pandemic Influenza Advisory Committee Meeting January 12, 2010 Mark J.

Advisory Committee on Blood Safety and Availability Strategic Plan Jerry A. Holmberg, Ph.D.

Imagine connecting a caring community. What is the Network? The Network is part of a state system built on the fundamental truth that thriving families.

OFFICE OF VACCINES RESEARCH AND REVIEW Center for Biologics Evaluation and Research Michael J. Brennan, Ph.D. Associate Director for Research OVRR Site.

The National Perspective: National Health Information Infrastructure (NHII): Key to the Future of Health Care Helga E. Rippen, MD, PhD, MPH Deputy Senior.

World Health Organization Department of Chronic Diseases and Health Promotion World Health Organization Strengthening Institutions: Indicators for Measuring.

SETTING SECURITY AND DEFENSE R&T POLICY Sofia, UNWE, June 28, 2007 Nikolay Pavlov Centre for National Security and Defense Research – Bulgarian Academy.

Putting people first, with the goal of helping all Michiganders lead healthier and more productive lives, no matter their stage in life. 1.

Presentation by Marsha Simon, Ph.D.

Partnership signing in 2001

Using Administrative Data for Federal Program Evaluation

Membership Management Highlights

HIMSS Advocacy Day Washington, DC April 1, 2004

Pharmacy Benefit Manager

An Enabling Business Environment and A Strategic Collaborative Approach for Sustainable Quality Local Production Africa Pharma Conference 4-5 June 2019,

An Enabling Business Environment and A Strategy and Collaborative Approach for Sustainable Quality Local Production Africa Pharma Conference 4-5 June 2019,

Presentation transcript:

AcademyHealth Research Meeting Barbara Greenberg, Ph.D. Office of Science and Data Policy Research ASPE, HHS June 8, 2004

I.Office of Science and Data Policy Research Agenda Goals: ( Address Administration and Secretarial Priorities e.g., Health Information Technology and Bioterrorism Focus on Issues and Activities of Department-Wide or Interagency Scope e.g., Health Effects of Mercury and Data Confidentiality

I.Office of Science and Data Policy Research Agenda Goals: Continued Address Major Analytic Gaps in HHS Science or Data Policy e.g. Medicaid Analytic eXtract (MAX) Data and Vital Statistics Data Enhance HHS and ASPE Data and Analytic Capabilities e.g., Geo-Coding of Data and Data Standards

II.Science and Data Policy Budget and Research Themes: Research Budget in 2004: $5 Million Three Major Research Themes:  Improving Information for Science Policy  Improving Data and Information for Decision-Making  Improving Health Through the National Health Information Infrastructure (NHII)

Prescription Drug Economics and Policy  Informing policy options and understanding prescription drug price variations  Identifying best practice cost containment strategies for health plans and States  Describing drug sector economics in the US and making international comparisons III. Improving Information for Science Policy

Medicare Modernization Act Implementation  Collaborating with FDA on studies to assess safety, efficacy and economic factors in drug importation policy Environmental Health Issues  Support for National Academy of Sciences review of dioxin health effects and HHS/EPA Conference on health effects of mercury III. Improving Information for Science Policy: Continued

National Vaccine Policy and Programs  Studies of supply, utilization and price variations of the influenza vaccine III. Improving Information for Science Policy: Continued

Analytical Support for the HHS Data Council and for the National Committee on Vital and Health Statistics (NCVHS) Projects that Improve HHS Data Bases and Resources IV. Improving Data and Information for Decision-Making

V.Improving Health through the National Health Information Infrastructure (NHII) Support of the NHII 2004 Conference, Cornerstones for Electronic Healthcare On July 20-23, 2004 ( Projects in Support of Evaluative, Leadership and Convener Activities